Owkin

Owkin company information, Employees & Contact Information

Explore related pages

Related company profiles:

Chemistry is no longer the biggest challenge in medicine — biology is, and it remains vastly more complex, dynamic, and poorly understood. The key to unlocking it is understanding and reversing biological aging, especially of the immune system, which drives most major diseases. OWKIN K is the first universal biology copilot, built on reinforcement learning and patient data from 80 of the world’s 100 largest hospitals, designed to discover, validate, and deploy rejuvenation-based interventions across pharma, CROs, biotechs, VCs, and LLM platforms. Led by top talent from Google Brain, Novartis, and DeepMind, OWKIN combines deep scientific credibility with a scalable SaaS + equity model tied to real-world clinical and commercial impact. We’re not building a tool — we’re building the operating system for the future of biology and medicine.
Looking for a particular Owkin employee's phone or email?

Owkin Questions

News

Owkin Launches K Pro: The First Agentic AI Co-Pilot for Biopharma Powered by Biological Reasoning Models - Pueblo Chieftain

Owkin Launches K Pro: The First Agentic AI Co-Pilot for Biopharma Powered by Biological Reasoning Models Pueblo Chieftain

Owkin Launches K Navigator, a Ground-breaking Agentic Co-pilot to Speed up Breakthroughs in Biomedical Research by 20x - Business Wire

Owkin Launches K Navigator, a Ground-breaking Agentic Co-pilot to Speed up Breakthroughs in Biomedical Research by 20x Business Wire

Owkin, an AI-Biotech Unicorn, Brings Its Cutting-Edge AI to Germany, Austria and Switzerland to Accelerate Research - Business Wire

Owkin, an AI-Biotech Unicorn, Brings Its Cutting-Edge AI to Germany, Austria and Switzerland to Accelerate Research Business Wire

Turning a data maze into a gold mine - Nature

Turning a data maze into a gold mine Nature

Owkin Unveils AI-Driven Oncology and Immunology Pipeline, In-Licenses Best-in-Class Asset OKN4395 - Business Wire

Owkin Unveils AI-Driven Oncology and Immunology Pipeline, In-Licenses Best-in-Class Asset OKN4395 Business Wire

CORRECTING and REPLACING Jean-Jacques Bienaimé Appointed Chairman of the Board at Owkin - Business Wire

CORRECTING and REPLACING Jean-Jacques Bienaimé Appointed Chairman of the Board at Owkin Business Wire

Owkin and Tribun Health Launch Strategic Partnership to Accelerate Access to AI Solutions for Diagnosis and Pharma Research - Newswire :) Press Release Distribution

Owkin and Tribun Health Launch Strategic Partnership to Accelerate Access to AI Solutions for Diagnosis and Pharma Research Newswire :) Press Release Distribution

Owkin Receives European Medicines Agency Letter of Support for Innovative AI-Driven Approach to Oncology Trial Analysis - ACN Newswire

Owkin Receives European Medicines Agency Letter of Support for Innovative AI-Driven Approach to Oncology Trial Analysis ACN Newswire

Owkin welcomes leading immuno-oncology professor as Chief Medical Officer and senior pharma exec as SVP Data Science - Newswire :) Press Release Distribution

Owkin welcomes leading immuno-oncology professor as Chief Medical Officer and senior pharma exec as SVP Data Science Newswire :) Press Release Distribution

Owkin Enters Into Agreement to Build Innovative Methods - GlobeNewswire

Owkin Enters Into Agreement to Build Innovative Methods GlobeNewswire

Owkin and The University of Pittsburgh Launch a - GlobeNewswire

Owkin and The University of Pittsburgh Launch a GlobeNewswire

Top Owkin Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant